Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$268.26 - $339.48 $400,780 - $507,183
1,494 New
1,494 $408,000
Q4 2023

Feb 26, 2024

BUY
$269.37 - $365.04 $275,296 - $373,070
1,022 New
1,022 $330,000
Q3 2022

Nov 07, 2022

BUY
$412.59 - $563.26 $650,241 - $887,697
1,576 Added 109.9%
3,010 $1.26 Million
Q2 2022

Aug 09, 2022

BUY
$463.67 - $597.16 $664,902 - $856,327
1,434 New
1,434 $710,000
Q3 2020

Dec 11, 2020

SELL
$454.43 - $535.6 $751,172 - $885,346
-1,653 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$334.87 - $493.06 $553,540 - $815,028
1,653 New
1,653 $746,000
Q4 2019

Feb 04, 2020

SELL
$319.73 - $374.2 $261,539 - $306,095
-818 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$304.55 - $345.24 $249,121 - $282,406
818 New
818 $272,000
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $1.55 Million - $1.69 Million
-5,414 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$224.3 - $317.41 $1.21 Million - $1.72 Million
5,414 New
5,414 $1.66 Million
Q4 2018

Jan 16, 2019

SELL
$220.1 - $309.0 $207,774 - $291,696
-944 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$289.28 - $326.15 $273,080 - $307,885
944 New
944 $295,000
Q2 2018

Jul 30, 2018

SELL
$244.1 - $303.88 $288,038 - $358,578
-1,180 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$244.1 - $303.88 $288,038 - $358,578
1,180 New
1,180 $340,000
Q1 2018

May 14, 2018

SELL
$233.97 - $274.11 $1.01 Million - $1.19 Million
-4,324 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$216.94 - $271.3 $432,578 - $540,972
1,994 Added 85.58%
4,324 $1.03 Million
Q3 2017

Nov 20, 2017

BUY
$212.27 - $242.28 $494,589 - $564,512
2,330
2,330 $518,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.46B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.